WebDrug type: Thiotepa is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "alkylating agent." (For more detail, see "How this drug … WebFind information on Thiotepa (Tepadina) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Davis Drug Guide PDF.
WO2024042944A1 - Composition for preventing, ameliorating, or …
WebThiotepa has been used intravesically for the treatment of residual tumours and as adjuvant therapy for prophylaxis of superficial bladder cancer. Thiotepa has also been used parenterally in the palliative treatment of … WebHow Tepadina (thiotepa) chemotherapy works, side effects, interactions and precautions. Get free tools to track your health. Skip Navigation ... you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online or by phone (1-800-332-1088). hobart locker crown point in
Thiotepa Uses, Side Effects & Warnings - Drugs.com
Web853 rows · N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable … WebThiotepa DRUG NAME: Thiotepa SYNONYM(S): TESPA, 1 TSPA 1. COMMON TRADE NAME(S): CLASSIFICATION: alkylating agent. Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Thiotepa, a derivative of nitrogen mustard, acts as a polyfunctional alkylating agent. 2. WebNov 8, 2013 · Thiotepa is a prescription medication used to treat certain types of ovarian, breast, and bladder cancers. It is also used to treat malignant effusions (a condition when fluid collects in the lungs or around the heart) that are caused by cancerous tumors. Thiotepa belongs to a group of drugs called alkylating agents. hr opentext